X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity

被引:10
作者
Karle, JM
机构
关键词
D O I
10.1128/AAC.41.4.791
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The crystal and molecular structures and absolute configuration of (-)-halofantrine hydrochloride were determined by X-ray diffraction, The absolute configuration of the single chiral center of (-)-halofantrine was established to be in the S configuration, Thus, (+)-halofantrine, the more cardiotoxic isomer, has the R configuration, The carbon atom adjacent to the aromatic ring has the same configuration in both (+)halofantrine and quinidine, suggesting a stereospecific component to the cardiotoxicity produced by both agents, The intramolecular N ... O distance is 4.177 +/- 0.006 Angstrom (1 Angstrom = 0.1 nm), which is close to the N ... O distance found in the crystal structure of (+/-)-halofantrine hydrochloride, even though the N-H group points in opposite directions in racemic halofantrine and (-)-halofantrine, Both the hydroxyl group and the amine group form hydrogen bonds With the chloride anions, The crystallographic parameters for (-)-halofantrine hydrochloride were as follows: chemical formula, C26H31Cl2F6NO+. Cl-; M(r) 492.4; symmetry of unit cell orthorhombic; space group(delta) P2(l)2(l)2(l); parameters of unit cell, a was 6.290 +/- 0.001 Angstrom, b was 13.533 +/- 0.003 Angstrom, and c was 30.936 +/- 0.006 Angstrom; volume of the unit cell, 2,633.2 +/- 0.7 Angstrom(3); number of molecules per unit cell, 4; calculated density, 1.354 g cm(-3); source of radiation, Cu K alpha (lambda = 1.54178 Angstrom); mu (adsorption coefficient), 3.50 (-1); F(000) (sum of atomic scattering factors at zero scattering angle), 1,120; room temperature was used; final R (residual index), 4.75% for 2,988 reflections, with \F-0\ > 3 sigma(F), where F-0 is the observed structure factor and F is the structure factor.
引用
收藏
页码:791 / 794
页数:4
相关论文
共 23 条
[1]   INVITRO ACTIVITY OF THE ENANTIOMERS OF MEFLOQUINE, HALOFANTRINE AND ENPIROLINE AGAINST PLASMODIUM-FALCIPARUM [J].
BASCO, LK ;
GILLOTIN, C ;
GIMENEZ, F ;
FARINOTTI, R ;
LEBRAS, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (05) :517-520
[2]  
BOUDREAU EF, 1988, B WORLD HEALTH ORGAN, V66, P227
[3]   HALOFANTRINE - A REVIEW OF ITS ANTIMALARIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL [J].
BRYSON, HM ;
GOA, KL .
DRUGS, 1992, 43 (02) :236-258
[4]   RESOLUTION OF ANTI-MALARIAL AGENTS VIA COMPLEX-FORMATION WITH ALPHA-(2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXY)PROPIONIC ACID [J].
CARROLL, FI ;
BERRANG, B ;
LINN, CP .
JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (04) :326-330
[5]   PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF HALOFANTRINE AND ITS MAIN METABOLITE IN MALARIA PATIENTS [J].
GIMENEZ, F ;
GILLOTIN, C ;
BASCO, LK ;
BOUCHAUD, O ;
AUBRY, AF ;
WAINER, IW ;
LEBRAS, J ;
FARINOTTI, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (06) :561-562
[6]   SIGNIFICANCE TESTS ON CRYSTALLOGRAPHIC R FACTOR [J].
HAMILTON, WC .
ACTA CRYSTALLOGRAPHICA, 1965, 18 :502-&
[7]  
Johnson C. K., 1976, ORNL5138
[8]   CLINICAL PHARMACOKINETICS OF HALOFANTRINE [J].
KARBWANG, J ;
BANGCHANG, KN .
CLINICAL PHARMACOKINETICS, 1994, 27 (02) :104-119
[9]   ANOMALOUS DISPERSION OF SULFUR IN QUINIDINE SULFATE, (C20H25N2O2)2SO4.2H2O - IMPLICATIONS FOR STRUCTURE-ANALYSIS [J].
KARLE, IL ;
KARLE, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-PHYSICAL SCIENCES, 1981, 78 (10) :5938-5941
[10]   SYMBOLIC ADDITION PROCEDURE FOR PHASE DETERMINATION FOR CENTROSYMMETRIC AND NONCENTROSYMMETRIC CRYSTALS [J].
KARLE, J ;
KARLE, IL .
ACTA CRYSTALLOGRAPHICA, 1966, 21 :849-&